We report a case of CD8(+)/V beta 5.1(+) T-cell large granular lymphocyte leukemia (T-LGL leukemia) presenting with mild lymphocytosis, severe autoimmune neutropenia, thrombocytopenia, polyarthritis and recurrent infections with a chronic disease course. Immunophenotyping showed an expansion of CD3(+)/TCR alpha beta(+)/CD8(+bright)/CD11c(+)/CD57(-)/CD56(-) large granular lymphocytes with expression of the TCR-V beta 5.1 family. Southern blot analysis revealed a clonal rearrangement of the TCR beta-chain gene. Hematopoietic growth factors, high dose intravenous immunoglobulin and corticosteroids were of limited therapeutic benefit to correct the cytopenias. During the disease course, the patient developed a severe cutaneous leg ulcer and bilateral vascular mammary skin lesions. Treatment with 2-deoxycoformycin resulted in both clinical and hematological complete responses, including the resolution of vascular skin lesions. Combined immuno-staining with relevant T-cell associated and anti-TCR-V beta monoclonal antibodies proved to be a sensitive method to assess the therapeutic effect of 2-deoxycoformicin and to evaluate the residual disease.

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.695DOI Listing

Publication Analysis

Top Keywords

large granular
12
skin lesions
12
cd8+/v beta
8
beta 51+
8
granular lymphocyte
8
lymphocyte leukemia
8
vascular mammary
8
mammary skin
8
disease course
8
51+ large
4

Similar Publications

Background: Health economic evaluations require cost data as a key input, and reimbursement policies and systems should incentivize valuable care. Subfertility is a growing global phenomenon, and Dutch per-treatment DRGs alone do not support value-based decision-making because they don't reflect patient-level variation or the impact of technologies on costs across entire patient pathways.

Methods: We present a real-world micro-costing analysis of subfertility patient pathways (n = 4.

View Article and Find Full Text PDF

Exchange-Biased Fe/FeF Nanocomposites: Unveiling the Structural Insights into Spin-Dependent Tunnel Transport.

ACS Appl Mater Interfaces

December 2024

Frontier Research Institute for Interdisciplinary Sciences, Tohoku University, Sendai 980-8578, Japan.

Spin-dependent charge tunneling transport of magnetic nanocomposites under alternating current or direct current has revolutionized the understanding of the quantum-mechanical phenomenon in complex granular solids. The tunnel magnetodielectric (TMD) and tunnel magnetoresistance (TMR) effects are two critical functionalities in this context, where dielectric permittivity and electrical resistance, respectively, change in response to an applied magnetic field due to charge tunneling. However, the structural correlation between TMD and TMR, as well as the mechanisms, remains poorly understood, largely due to the challenges in directly characterizing nanoscale intergranular interactions.

View Article and Find Full Text PDF

Based on the analysis of the structures of robots and electronics developed so far, it should be noted that a majority of them need a reservoir for electrical energy storage. Unfortunately, most off-the-shelf devices commercially available nowadays are based on rigid parts that heavily limit the possibilities of incorporating such products into soft robots and wearable electronics. To address these issues, a new type of flexible structure for electrical energy storage, which consists of small battery cells connected by liquid metal paths, was proposed.

View Article and Find Full Text PDF

Introduction: We investigated whether the cerebellum develops neuropathology that correlates with well-accepted Alzheimer's disease (AD) neuropathological markers and cognitive status.

Methods: We studied cerebellar cytoarchitecture in a cohort (N = 30) of brain donors. In a larger cohort (N = 605), we queried whether the weight of the contents of the posterior fossa (PF), which contains primarily cerebellum, correlated with dementia status.

View Article and Find Full Text PDF

Background: U.S. FDA's Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative leverages large electronic health records and administrative claims data to conduct active surveillance for CBER-regulated products.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!